Literature DB >> 18062389

Obesity in civilian adults: potential impact on eligibility for U.S. military enlistment.

Grover K Yamane1.   

Abstract

OBJECTIVE: This study measures the prevalence in the civilian adult population of obesity for military enlistment.
METHODS: The National Health and Nutrition Examination Survey for 2001-2004 was used to obtain a sample of civilian adults 17 to 42 years of age. Weight standards for each branch of service were applied to determine the proportion of subjects who were over maximal weight limits and thus ineligible for enlistment.
RESULTS: Depending on the branch of service and the age range, 17.9% to 54.4% of men and 20.8% to 54.9% of women were overweight for enlistment. Generally, there were higher prevalence rates in the older age groups and among women. Prevalence rates for non-Caucasian subjects were not higher among men but were higher among women.
CONCLUSION: Large proportions of civilian adults are over the weight limits for military enlistment. The currently increasing prevalence of obesity in the civilian population may pose a challenge for military recruitment programs.

Entities:  

Mesh:

Year:  2007        PMID: 18062389     DOI: 10.7205/milmed.172.11.1160

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  3 in total

Review 1.  Obesity Prevention in the Military.

Authors:  Marissa Shams-White; Patricia Deuster
Journal:  Curr Obes Rep       Date:  2017-06

2.  Effects of a healthy food supply intervention in a military setting: positive changes in cereal, fat and sugar containing foods.

Authors:  Clarissa M L Bingham; Marjaana Lahti-Koski; Pauli Puukka; Marja Kinnunen; Piia Jallinoja; Pilvikki Absetz
Journal:  Int J Behav Nutr Phys Act       Date:  2012-07-31       Impact factor: 6.457

3.  Factors affecting the prevalence of obesity among primary school students in Turkey.

Authors:  Tulay Kuzlu Ayyildiz; Meltem Kurtuncu; Hulya Kulakci; Sevim Celik
Journal:  Iran Red Crescent Med J       Date:  2014-12-14       Impact factor: 0.611

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.